Loading...

Teva Pharmaceutical Industries Limited

TEVJFPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$14.32
$0.00(0.00%)

Teva Pharmaceutical Industries Limited (TEVJF) Stock Competitors & Peer Comparison

See (TEVJF) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
TEVJF$14.32+0.00%16.4B-95.47-$0.15N/A
MKGAF$130.35+0.00%57.8B17.32$7.68+1.88%
MKKGY$26.11-0.01%56.7B17.02$1.53+1.92%
TKPHF$28.56-0.01%46B50.78$0.58+4.52%
HLNCF$4.95+0.00%44.9B23.81$0.21+1.74%
IPSEY$31.14+0.00%41.8B20.14$1.57+0.82%
SDZNY$59.31+0.00%25.5B114.07$0.52+1.14%
ESALY$61.51-2.11%17.6B20.54$3.00N/A
SGIOY$9.07+0.00%15.5B13.37$0.68+1.74%
SGIOF$16.79+0.00%14.3B12.35$1.36+4.84%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

TEVJF vs MKGAF Comparison August 2025

TEVJF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TEVJF stands at 16.4B. In comparison, MKGAF has a market cap of 57.8B. Regarding current trading prices, TEVJF is priced at $14.32, while MKGAF trades at $130.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TEVJF currently has a P/E ratio of -95.47, whereas MKGAF's P/E ratio is 17.32. In terms of profitability, TEVJF's ROE is -0.03%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, TEVJF is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for TEVJF.Check MKGAF's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;